title: Reply to Huang et al.
authors.affiliation: Internal Medicine, University of Naples S.U.N. and Monaldi Hospital, Naples, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Utili
authors.forename: Emanuele
authors.initials: E
authors.lastname: Durante-Mangoni
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003091:Colistin / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D012293:Rifampin; D003091:Colistin